| 000 | 01403 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514160008.0 | ||
| 264 | 0 | _c20040206 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a1381-6128 | ||
| 024 | 7 |
_a10.2174/1381612033453947 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKunapuli, Satya P | |
| 245 | 0 | 0 |
_aADP receptors--targets for developing antithrombotic agents. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2003 |
||
| 300 |
_a2303-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 | _aReceptors, Purinergic P2X |
| 650 | 0 | 4 | _aReceptors, Purinergic P2Y1 |
| 650 | 0 | 4 | _aReceptors, Purinergic P2Y12 |
| 700 | 1 | _aDing, Zhongren | |
| 700 | 1 | _aDorsam, Robert T | |
| 700 | 1 | _aKim, Soochong | |
| 700 | 1 | _aMurugappan, Swaminathan | |
| 700 | 1 | _aQuinton, Todd M | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 9 _gno. 28 _gp. 2303-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612033453947 _zAvailable from publisher's website |
| 999 |
_c14289068 _d14289068 |
||